LeaderPortfolio
Laukien
Frank Laukien
Rank #2838
UNITED STATESManufacturingScientific equipment

Frank Laukien

Net Worth
$1.349B
+0.21% (24h)
Frank Laukien is the Chairman, President, and CEO of Bruker Corporation, a leading manufacturer of scientific instruments. With a net worth of $1.5 billion, he is the largest shareholder of the company. Laukien's career has been centered on advancing scientific innovation and expanding Bruker's global presence in the scientific equipment industry. He holds a Ph.D. in chemical physics from Harvard University and a Bachelor of Science degree in physics from MIT, where he studied economics and accounting. His leadership has transformed Bruker into a major player in life sciences, materials research, and biopharma applications.

The Full Dossier

Early Life

Frank H. Laukien was born in 1960 in Stuttgart, Germany. He is the son of Günther Laukien, the founder of Bruker Corporation. His mother was a high school teacher. Laukien's upbringing in a family involved in the scientific instrument industry shaped his early interest in physics and technology.

Rise to Success

Laukien earned a Bachelor of Science degree in physics from the Massachusetts Institute of Technology (MIT) and a Ph.D. in chemical physics from Harvard University. He started working at Bruker during his summers in college. After completing his doctorate, he joined Bruker full-time. He was appointed Chairman, President, and CEO of Bruker Corporation in February 1991.

Key Business Strategies

Under Laukien's leadership, Bruker went public on NASDAQ in 2000 and expanded through strategic acquisitions and R&D investments. Laukien owns approximately 26% of the publicly traded firm. The company focuses on advanced technologies like mass spectrometry, X-ray diffraction, and magnetic resonance. Bruker's revenue for 2025 was $3.44 billion.

Philanthropy

Laukien has made significant contributions to scientific research initiatives, including supporting an MIT glycobiology program. He has also served as a visiting scholar at Harvard University's Origins of Life Initiative and supports cancer research.

Career Timeline

2024

Glycobiology Program

Announced support for an MIT glycobiology program

2000

Bruker Goes Public

Led Bruker Corporation to go public on NASDAQ.

1991

CEO of Bruker Corporation

Appointed Chairman, President, and Chief Executive Officer of Bruker Corporation.

1988

Received a PhD from Harvard

Completed a doctorate in chemical physics.

1984

Graduated from MIT

Earned a Bachelor of Science degree in physics.

Philanthropic Impact

Research$XB

MIT Glycobiology Program

Funding efforts to advance research in this field through collaborations across the institute.

Wealth Trajectory